Effect of maternal obesity on Maternal-Fetal transfer of preoperative cefazolin at cesarean section

Stephanie Mckenney Groff, Wareef Fallatah, Samuel Yang, Jamie Murphy, Christopher Crutchfield, Mark A Marzinke, Joanne Kurtzberg, Carlton K Lee, Irina Burd, Farzin Azadeh

Research output: Contribution to journalArticle

Abstract

OBJECTIVES American Congress of Obstetricians and Gynecologists recommends a single dose of antibiotic prophylaxis before all cesarean sections (C/S). This recommendation is based on pharmacokinetic studies that include only non-obese patients. We sought to evaluate 1) cefazolin plasma concentrations among obese and non-obese patients after administration of a 2-g cefazolin dose for prevention of surgical wound infections, and 2) whether cefazolin concentration in fetal circulation may be protective against pathogens that cause early onset neonatal sepsis. METHODS Maternal and fetal cefazolin plasma concentrations were compared between obese (body mass index [BMI] ≥ 30 kg/m2) and non-obese (BMI < 25 kg/m2) healthy, term pregnant women undergoing scheduled C/S. Liquid chromatographic–tandem mass spectrometric (LC-MS/MS) methods were used for quantification of total and free cefazolin concentrations in maternal blood (MB) and umbilical cord blood (UCB). RESULTS Eight women were screened and consented. There was no difference between groups in MB total and free cefazolin concentrations. All MB samples had total and free cefazolin concentrations greater than the minimum inhibitory concentration 90 (MIC90) for Group B Streptococcus (GBS), Staphylococcus aureus, and Escherichia coli. All UCB samples had total and free cefazolin concentrations greater than MIC90 for GBS and S aureus, even when administered as briefly as 18 minutes before delivery. A lower concentration of total cefazolin was detected in UCB of neonates of obese women compared to non-obese women (p > 0.05).CONCLUSIONS Administration of 2 g of cefazolin to women undergoing scheduled C/S might be an adequate prophylactic dose for surgical wound infection in both non-obese and obese patients; and cefazolin concentration in fetal circulation may be protective against GBS and S aureus.

Original languageEnglish (US)
Pages (from-to)227-232
Number of pages6
JournalJournal of Pediatric Pharmacology and Therapeutics
Volume22
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Cefazolin
Cesarean Section
Obesity
Mothers
Surgical Wound Infection
Body Mass Index
Antibiotic Prophylaxis
Pharmacokinetics

Keywords

  • Antibiotic prophylaxis
  • Cefazolin
  • Obesity
  • Pregnancy
  • Surgical wound infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pharmacology (medical)

Cite this

Effect of maternal obesity on Maternal-Fetal transfer of preoperative cefazolin at cesarean section. / Groff, Stephanie Mckenney; Fallatah, Wareef; Yang, Samuel; Murphy, Jamie; Crutchfield, Christopher; Marzinke, Mark A; Kurtzberg, Joanne; Lee, Carlton K; Burd, Irina; Azadeh, Farzin.

In: Journal of Pediatric Pharmacology and Therapeutics, Vol. 22, No. 3, 01.05.2017, p. 227-232.

Research output: Contribution to journalArticle

Groff, Stephanie Mckenney ; Fallatah, Wareef ; Yang, Samuel ; Murphy, Jamie ; Crutchfield, Christopher ; Marzinke, Mark A ; Kurtzberg, Joanne ; Lee, Carlton K ; Burd, Irina ; Azadeh, Farzin. / Effect of maternal obesity on Maternal-Fetal transfer of preoperative cefazolin at cesarean section. In: Journal of Pediatric Pharmacology and Therapeutics. 2017 ; Vol. 22, No. 3. pp. 227-232.
@article{3c4fe207c7bb482a91e66b3d4517985f,
title = "Effect of maternal obesity on Maternal-Fetal transfer of preoperative cefazolin at cesarean section",
abstract = "OBJECTIVES American Congress of Obstetricians and Gynecologists recommends a single dose of antibiotic prophylaxis before all cesarean sections (C/S). This recommendation is based on pharmacokinetic studies that include only non-obese patients. We sought to evaluate 1) cefazolin plasma concentrations among obese and non-obese patients after administration of a 2-g cefazolin dose for prevention of surgical wound infections, and 2) whether cefazolin concentration in fetal circulation may be protective against pathogens that cause early onset neonatal sepsis. METHODS Maternal and fetal cefazolin plasma concentrations were compared between obese (body mass index [BMI] ≥ 30 kg/m2) and non-obese (BMI < 25 kg/m2) healthy, term pregnant women undergoing scheduled C/S. Liquid chromatographic–tandem mass spectrometric (LC-MS/MS) methods were used for quantification of total and free cefazolin concentrations in maternal blood (MB) and umbilical cord blood (UCB). RESULTS Eight women were screened and consented. There was no difference between groups in MB total and free cefazolin concentrations. All MB samples had total and free cefazolin concentrations greater than the minimum inhibitory concentration 90 (MIC90) for Group B Streptococcus (GBS), Staphylococcus aureus, and Escherichia coli. All UCB samples had total and free cefazolin concentrations greater than MIC90 for GBS and S aureus, even when administered as briefly as 18 minutes before delivery. A lower concentration of total cefazolin was detected in UCB of neonates of obese women compared to non-obese women (p > 0.05).CONCLUSIONS Administration of 2 g of cefazolin to women undergoing scheduled C/S might be an adequate prophylactic dose for surgical wound infection in both non-obese and obese patients; and cefazolin concentration in fetal circulation may be protective against GBS and S aureus.",
keywords = "Antibiotic prophylaxis, Cefazolin, Obesity, Pregnancy, Surgical wound infection",
author = "Groff, {Stephanie Mckenney} and Wareef Fallatah and Samuel Yang and Jamie Murphy and Christopher Crutchfield and Marzinke, {Mark A} and Joanne Kurtzberg and Lee, {Carlton K} and Irina Burd and Farzin Azadeh",
year = "2017",
month = "5",
day = "1",
doi = "10.5863/1551-6776-22.3.227",
language = "English (US)",
volume = "22",
pages = "227--232",
journal = "Journal of Pediatric Pharmacology and Therapeutics",
issn = "1551-6776",
publisher = "Pediatric Pharmacology Advocacy Group, Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of maternal obesity on Maternal-Fetal transfer of preoperative cefazolin at cesarean section

AU - Groff, Stephanie Mckenney

AU - Fallatah, Wareef

AU - Yang, Samuel

AU - Murphy, Jamie

AU - Crutchfield, Christopher

AU - Marzinke, Mark A

AU - Kurtzberg, Joanne

AU - Lee, Carlton K

AU - Burd, Irina

AU - Azadeh, Farzin

PY - 2017/5/1

Y1 - 2017/5/1

N2 - OBJECTIVES American Congress of Obstetricians and Gynecologists recommends a single dose of antibiotic prophylaxis before all cesarean sections (C/S). This recommendation is based on pharmacokinetic studies that include only non-obese patients. We sought to evaluate 1) cefazolin plasma concentrations among obese and non-obese patients after administration of a 2-g cefazolin dose for prevention of surgical wound infections, and 2) whether cefazolin concentration in fetal circulation may be protective against pathogens that cause early onset neonatal sepsis. METHODS Maternal and fetal cefazolin plasma concentrations were compared between obese (body mass index [BMI] ≥ 30 kg/m2) and non-obese (BMI < 25 kg/m2) healthy, term pregnant women undergoing scheduled C/S. Liquid chromatographic–tandem mass spectrometric (LC-MS/MS) methods were used for quantification of total and free cefazolin concentrations in maternal blood (MB) and umbilical cord blood (UCB). RESULTS Eight women were screened and consented. There was no difference between groups in MB total and free cefazolin concentrations. All MB samples had total and free cefazolin concentrations greater than the minimum inhibitory concentration 90 (MIC90) for Group B Streptococcus (GBS), Staphylococcus aureus, and Escherichia coli. All UCB samples had total and free cefazolin concentrations greater than MIC90 for GBS and S aureus, even when administered as briefly as 18 minutes before delivery. A lower concentration of total cefazolin was detected in UCB of neonates of obese women compared to non-obese women (p > 0.05).CONCLUSIONS Administration of 2 g of cefazolin to women undergoing scheduled C/S might be an adequate prophylactic dose for surgical wound infection in both non-obese and obese patients; and cefazolin concentration in fetal circulation may be protective against GBS and S aureus.

AB - OBJECTIVES American Congress of Obstetricians and Gynecologists recommends a single dose of antibiotic prophylaxis before all cesarean sections (C/S). This recommendation is based on pharmacokinetic studies that include only non-obese patients. We sought to evaluate 1) cefazolin plasma concentrations among obese and non-obese patients after administration of a 2-g cefazolin dose for prevention of surgical wound infections, and 2) whether cefazolin concentration in fetal circulation may be protective against pathogens that cause early onset neonatal sepsis. METHODS Maternal and fetal cefazolin plasma concentrations were compared between obese (body mass index [BMI] ≥ 30 kg/m2) and non-obese (BMI < 25 kg/m2) healthy, term pregnant women undergoing scheduled C/S. Liquid chromatographic–tandem mass spectrometric (LC-MS/MS) methods were used for quantification of total and free cefazolin concentrations in maternal blood (MB) and umbilical cord blood (UCB). RESULTS Eight women were screened and consented. There was no difference between groups in MB total and free cefazolin concentrations. All MB samples had total and free cefazolin concentrations greater than the minimum inhibitory concentration 90 (MIC90) for Group B Streptococcus (GBS), Staphylococcus aureus, and Escherichia coli. All UCB samples had total and free cefazolin concentrations greater than MIC90 for GBS and S aureus, even when administered as briefly as 18 minutes before delivery. A lower concentration of total cefazolin was detected in UCB of neonates of obese women compared to non-obese women (p > 0.05).CONCLUSIONS Administration of 2 g of cefazolin to women undergoing scheduled C/S might be an adequate prophylactic dose for surgical wound infection in both non-obese and obese patients; and cefazolin concentration in fetal circulation may be protective against GBS and S aureus.

KW - Antibiotic prophylaxis

KW - Cefazolin

KW - Obesity

KW - Pregnancy

KW - Surgical wound infection

UR - http://www.scopus.com/inward/record.url?scp=85041004980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041004980&partnerID=8YFLogxK

U2 - 10.5863/1551-6776-22.3.227

DO - 10.5863/1551-6776-22.3.227

M3 - Article

C2 - 28638306

AN - SCOPUS:85041004980

VL - 22

SP - 227

EP - 232

JO - Journal of Pediatric Pharmacology and Therapeutics

JF - Journal of Pediatric Pharmacology and Therapeutics

SN - 1551-6776

IS - 3

ER -